CSIMarket
 


Bioadaptives Inc   (BDPT)
Other Ticker:  
 

Bioadaptives Inc 's Quick Ratio

BDPT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 0 a new company low.

Within Major Pharmaceutical Preparations industry 496 other companies have achieved higher Quick Ratio than Bioadaptives Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 4461 to 4648.

Explain Quick Ratio?
How much Cash & cash equivalents BDPT´s has?
What are BDPT´s Current Liabilities?


BDPT Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change -9.25 % 6.47 % 10.67 % 19.91 % 16.86 %
Y / Y Cash & cash equivalent Change -99.94 % -99.96 % -99.94 % -69.39 % -73.09 %
Quick Ratio MRQ 0 0 0 0.02 0.01
BDPT's Total Ranking # 4648 # 4461 # 4158 # 4440 # 4907
Seq. Current Liabilities Change -11.43 % 1.33 % 10.4 % -8.41 % 3.91 %
Seq. Cash & cash equivalent Change -47.62 % -34.38 % -99.87 % 41.84 % -63.81 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 497
Healthcare Sector # 1029
Overall Market # 4648


Quick Ratio Statistics
High Average Low
5.82 0.45 0
(Mar 31 2014)   (Sep 30 2023)




Financial Statements
Bioadaptives Inc 's Current Liabilities $ 1 Millions Visit BDPT's Balance sheet
Bioadaptives Inc 's Cash & cash equivalent $ 0 Millions Visit BDPT's Balance sheet
Source of BDPT's Sales Visit BDPT's Sales by Geography


Cumulative Bioadaptives Inc 's Quick Ratio

BDPT's Quick Ratio for the trailling 12 Months

BDPT Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -9.25 % 6.47 % 10.67 % 19.91 % 16.86 %
Y / Y Cash & cash equivalent TTM Growth -99.94 % -99.96 % -99.94 % -69.39 % -73.09 %
Quick Ratio TTM 0 0.01 0.01 0.02 0.03
Total Ranking TTM # 3879 # 4095 # 4194 # 4714 # 4430
Seq. Current Liabilities TTM Growth -11.43 % 1.33 % 10.4 % -8.41 % 3.91 %
Seq. Cash & cash equivalent TTM Growth -47.62 % -34.38 % -99.87 % 41.84 % -63.81 %


On the trailing twelve months basis In spite of the year on year decrease in BDPT's Current Liabilities to $1.48 millions, cumulative Quick Ratio to 0 below the BDPT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 504 other companies have achieved higher Quick Ratio than Bioadaptives Inc . While Quick Ratio overall ranking has improved so far to 3959, from total ranking during the twelve months ending second quarter 2023 at 4096.

Explain Quick Ratio?
How much Cash & cash equivalents BDPT´s has?
What are BDPT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 505
Healthcare Sector # 1045
Within the Market # 4648


trailing twelve months Quick Ratio Statistics
High Average Low
0.75 0.08 0
(Mar 31 2015)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Bioadaptives Inc 0.00 $ 0.000  Millions$ 1.475  Millions

Date modified: 2023-11-14T17:45:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com